Group One Trading
CDAK

Group One Trading’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Group One Trading’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200
Closed -$2K – 9015
2021
Q4 		$2K Buy
+200
New +$2.77K ﹤0.01% 7940

Other funds holding CDAK

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $110M AUM 18.54% 1-Year Est. Return
PM
Parametrica Management Wanchai, Hong Kong $88M AUM 48.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Group One Trading's CDAK Position: Q1 2023 in Review

Group One Trading sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q1 2023, closing a stake of 22 shares — an estimated $9 sold.

Group One Trading first reported a position in CDAK in Q3 2021 and held it in 6 quarters. The position peaked at $9 in Q4 2022. 27 funds tracked by Wall St. Rank hold CDAK as of Q1 2023.

  • Group One Trading reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 22 Codiak BioSciences, Inc. Common Stock shares in Q1 2023, an estimated $9.
  • Group One Trading first reported a position in Codiak BioSciences, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Group One Trading's Codiak BioSciences, Inc. Common Stock position peaked at $9 in Q4 2022.
  • 27 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.